142732 people have viewed this drug in the last 60 days
Updated 2025-04-29
| Last Update | 2023-03-28 |
| Register Year | 2016 |
| Product Type | Human |
| Drug Type | NCE |
| Scientific Name | PALBOCICLIB |
| Trade Name | IBRANCE 125 mg capsule |
| Strength Unit | mg |
| Pharmaceutical Form | Capsule |
| Administration Route | Oral use |
| Atc Code1 | L01XE33 |
| Atc Code2 | |
| Size | 0 |
| Size Unit | |
| Package Types | Bottle |
| Package Size | 21 |
| Legal Status | Prescription |
| Product Control | Uncontrolled |
| Distribute Area | Hospital |
| Public price | $16230.6 |
| Shelf Life | 36 Months |
| Marketing Company | PFIZER |
| Marketing Country | United States |
| Manufacture Name | Pfizer Manufacturing Deutschland GmbH |
| Manufacture Country | Germany |
| Secondry package manufacture | |
| Main Agent | Abdulrehman Algosaibi G.T.C. |
| Secosnd Agent | |
| Third Agent | |
| Visits | 142732 |
Do not forget, after purchasing the medicine, help us determine the price more accurately, press the button below and adjust the price directly
| Name | Price | Visits | Updated |
|---|---|---|---|
| IBRANCE 125 mg capsule | $16230.6 | 142732 visits | 2023-03-28 |
| IBRANCE 100 mg capsule | $16230.6 | 134768 visits | 2023-03-28 |
| IBRANCE 75 mg capsule | $16230.6 | 227109 visits | 2023-03-27 |